![]() |
市場調查報告書
商品編碼
1279738
2022-2029年全球靜脈注射液市場規模研究和預測,按類型、按溶液成分和區域分析Global Intravenous Solutions Market Size study & Forecast, by Type by Solution Composition and Regional Analysis, 2022-2029 |
靜脈注射 (IV) 溶液是通過靜脈直接注入患者血液的無菌液體。它們通常用於醫院、診所和其他醫療環境,為無法口服這些物質的患者提供水合作用、藥物、營養素或其他治療劑。靜脈注射液可以包含水、電解質、糖、維生素和藥物的各種組合,具體取決於患者的需要。它們有不同的濃度和類型,例如等滲、低滲和高滲,這決定了它們對身體體液平衡的影響。推動市場增長的關鍵因素是營養不良患病率的上升,以及為患者提供便利的產品的進步和新創新,預計將在預測期內支援市場增長。
此外,以靜脈溶液為患者主要能源的胃腸道疾病、神經系統疾病和癌症等疾病的流行是市場增長的主要貢獻者之一。根據世界衛生組織的數據,2019年有37萬人死亡,腹瀉是五歲以下兒童死亡的第二大原因。便攜式包裝解決方案的可用性,使患者更容易在舒適的家中而不是在醫院使用點滴,以及產品創新,如預混合解決方案,以提高便利性和減少包裝廢物量是推動市場增長的其他一些因素。例如,2019年6月,專業輸液和藥品的製造商和經銷商Eurolife Healthcare推出了用戶友好和減少傳染病的靜脈注射設備Discport和Lifeport。此外,在預測期內,不斷增長的老年人口預計將為市場創造有利可圖的機會。然而,在2022-2029年的預測期內,缺乏有經驗的醫護人員和靜脈給藥治療的並發症扼殺了市場增長。
全球靜脈注射解決方案市場研究的主要地區包括亞太地區、北美、歐洲、拉丁美洲和世界其他地區。由於主要市場參與者的存在,以及該地區老年人口的增加,北美是全球市場佔有率的主導地區。而亞太地區在預測期內也將表現出最高的增長率,這是因為慢性病發病率上升、各利益相關方之間的合作數量增加以及老齡人口增加等因素將為整個亞太地區的靜脈注射液市場創造有利的增長前景。
該研究的目的是定義近年來不同市場區隔和國家的市場規模,並預測未來幾年的價值。該報告旨在涵蓋參與研究的國家/地區的該行業的定性和定量方面。
該報告還提供了關於關鍵方面的詳細資訊,如驅動因素和挑戰,這將確定市場的未來增長。此外,它還涵蓋了微觀市場的潛在機會,供利益相關者投資,並詳細分析了競爭格局和主要參與者的產品。 .
Global Intravenous Solutions Market is valued approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Intravenous (IV) solutions are sterile fluids that are administered directly into a patient's bloodstream through a vein. They are commonly used in hospitals, clinics, and other medical settings to provide hydration, medications, nutrients, or other therapeutic agents to patients who are unable to take these substances orally. IV solutions can contain various combinations of water, electrolytes, sugars, vitamins, and medications, depending on the patient's needs. They come in different concentrations and types, such as isotonic, hypotonic, and hypertonic, which determine their effect on the body's fluid balance. The key factor driving the market growth is rise in prevalence of malnutrition, and advancements and new innovations in the products for patient convenience that anticipated to support the market growth during forecast period.
Moreover, the prevalence of diseases such gastrointestinal disorders, neurological diseases, and cancer, wherein intravenous solutions are the primary energy sources for patients, is one of the main contributors to the market's growth. With 370,000 deaths in 2019, diarrhea is the second most common cause of death in children under the age of five, according to the World Health Organization. Also, the availability of solutions in portable packages, which makes it simpler for patients to use the drips in the comfort of their homes rather than at a hospital, and product innovations such as premixed solutions for improved convenience and to reduce the amount of packaging waste are a few other factors boosting the market's growth. For instance, in June 2019, Eurolife Healthcare, a manufacturer and distributor of specialty infusion and pharmaceuticals, introduced the user-friendly and infectious disease-reduction intravenous IV devices Discport and Lifeport. Additionally, growing geriatric population is anticipated to create the lucrative opportunity for the market during forecast period. However, lack of experienced healthcare professionals and complications of intravenous administration therapy stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Intravenous Solutions Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the presence of key market players, and rise in the geriatric population in the region. Whereas, Asia Pacific is also anticipated to exhibit highest growth rate over the forecast period, owing to factors such as rising prevalence of chronic diseases, increasing number of collaborations between various stakeholders and rising old age population would create lucrative growth prospects for the Intravenous Solutions market across Asia Pacific region.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable